Docoh
Loading...

NBTX Nanobiotix

Filed: 14 Apr 21, 4:15pm



 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
 
Date of Report: April 14, 2021
 
Commission File Number: 001-39777
 
Nanobiotix S.A.
(Exact Name of Registrant as Specified in its Charter)
 
60 Rue de Wattignies
75012 Paris, France
(Address of principal executive office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
Form 20-F Form 40-F
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): 

In connection with the Annual Combined General Meeting of Shareholders (the “Meeting”) of Nanobiotix S.A. (the “Company”), the following document, which is incorporated by reference herein, provides the full text of the resolutions to be considered at the meeting:


EXHIBIT INDEX
ExhibitTitle
  



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 

 
NANOBIOTIX S.A.
(Registrant)
  
April 14, 2021By:
/s/ Philippe Mauberna
  Philippe Mauberna
  Chief Financial Officer